Cargando…

Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer

BACKGROUND: The Korean Radiation Oncology Group (KROG) 19 − 09 prospective cohort study aims to determine the effect of regional nodal irradiation on regional recurrence rates in ypN0 breast cancer patients. Dosimetric variations between radiotherapy (RT) plans of participating institutions may affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Myeongsoo, Park, Boram, Kim, Haksoo, Kim, Yeon-Joo, Choi, Dong Ju, Chung, Weonkuu, Kim, Yeon Joo, Shin, Hyun Soo, Im, Jung Ho, Suh, Chang-Ok, Kim, Jin Hee, Ha, Boram, Kim, Mi Young, Park, Jongmoo, Lee, Jeongshim, Ahn, Sung-Ja, Lee, Sun Young, Kusumawidjaja, Grace, Lim, Faye, Cho, Won Kyung, Kim, Haeyoung, Choi, Doo Ho, Park, Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670516/
https://www.ncbi.nlm.nih.gov/pubmed/36384804
http://dx.doi.org/10.1186/s13014-022-02140-0
_version_ 1784832351005573120
author Kim, Myeongsoo
Park, Boram
Kim, Haksoo
Kim, Yeon-Joo
Choi, Dong Ju
Chung, Weonkuu
Kim, Yeon Joo
Shin, Hyun Soo
Im, Jung Ho
Suh, Chang-Ok
Kim, Jin Hee
Ha, Boram
Kim, Mi Young
Park, Jongmoo
Lee, Jeongshim
Ahn, Sung-Ja
Lee, Sun Young
Kusumawidjaja, Grace
Lim, Faye
Cho, Won Kyung
Kim, Haeyoung
Choi, Doo Ho
Park, Won
author_facet Kim, Myeongsoo
Park, Boram
Kim, Haksoo
Kim, Yeon-Joo
Choi, Dong Ju
Chung, Weonkuu
Kim, Yeon Joo
Shin, Hyun Soo
Im, Jung Ho
Suh, Chang-Ok
Kim, Jin Hee
Ha, Boram
Kim, Mi Young
Park, Jongmoo
Lee, Jeongshim
Ahn, Sung-Ja
Lee, Sun Young
Kusumawidjaja, Grace
Lim, Faye
Cho, Won Kyung
Kim, Haeyoung
Choi, Doo Ho
Park, Won
author_sort Kim, Myeongsoo
collection PubMed
description BACKGROUND: The Korean Radiation Oncology Group (KROG) 19 − 09 prospective cohort study aims to determine the effect of regional nodal irradiation on regional recurrence rates in ypN0 breast cancer patients. Dosimetric variations between radiotherapy (RT) plans of participating institutions may affect the clinical outcome of the study. We performed this study to assess inter-institutional dosimetric variations by dummy run. METHODS: Twelve participating institutions created RT plans for four clinical scenarios using computed tomography images of two dummy cases. Based on a reference structure set, we analyzed dose-volume histograms after collecting the RT plans. RESULTS: We found variations in dose distribution between institutions, especially in the regional nodal areas. Whole breast and regional nodal irradiation (WBI + RNI) plans had lower inter-institutional agreement and similarity for 95% isodose lines than WBI plans. Fleiss’s kappa values, which were used to measure inter-institutional agreement for the 95% isodose lines, were 0.830 and 0.767 for the large and medium breast WBI plans, respectively, and 0.731 and 0.679 for the large and medium breast WBI + RNI plans, respectively. There were outliers in minimum dose delivered to 95% of the structure (D95%) of axillary level 1 among WBI plans and in D95% of the interpectoral region and axillary level 4 among WBI + RNI plans. CONCLUSION: We found inter-institutional and inter-case variations in radiation dose delivered to target volumes and organs at risk. As KROG 19 − 09 is a prospective cohort study, we accepted the dosimetric variation among the different institutions. Actual patient RT plan data should be collected to achieve reliable KROG 19 − 09 study results.
format Online
Article
Text
id pubmed-9670516
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96705162022-11-18 Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer Kim, Myeongsoo Park, Boram Kim, Haksoo Kim, Yeon-Joo Choi, Dong Ju Chung, Weonkuu Kim, Yeon Joo Shin, Hyun Soo Im, Jung Ho Suh, Chang-Ok Kim, Jin Hee Ha, Boram Kim, Mi Young Park, Jongmoo Lee, Jeongshim Ahn, Sung-Ja Lee, Sun Young Kusumawidjaja, Grace Lim, Faye Cho, Won Kyung Kim, Haeyoung Choi, Doo Ho Park, Won Radiat Oncol Research BACKGROUND: The Korean Radiation Oncology Group (KROG) 19 − 09 prospective cohort study aims to determine the effect of regional nodal irradiation on regional recurrence rates in ypN0 breast cancer patients. Dosimetric variations between radiotherapy (RT) plans of participating institutions may affect the clinical outcome of the study. We performed this study to assess inter-institutional dosimetric variations by dummy run. METHODS: Twelve participating institutions created RT plans for four clinical scenarios using computed tomography images of two dummy cases. Based on a reference structure set, we analyzed dose-volume histograms after collecting the RT plans. RESULTS: We found variations in dose distribution between institutions, especially in the regional nodal areas. Whole breast and regional nodal irradiation (WBI + RNI) plans had lower inter-institutional agreement and similarity for 95% isodose lines than WBI plans. Fleiss’s kappa values, which were used to measure inter-institutional agreement for the 95% isodose lines, were 0.830 and 0.767 for the large and medium breast WBI plans, respectively, and 0.731 and 0.679 for the large and medium breast WBI + RNI plans, respectively. There were outliers in minimum dose delivered to 95% of the structure (D95%) of axillary level 1 among WBI plans and in D95% of the interpectoral region and axillary level 4 among WBI + RNI plans. CONCLUSION: We found inter-institutional and inter-case variations in radiation dose delivered to target volumes and organs at risk. As KROG 19 − 09 is a prospective cohort study, we accepted the dosimetric variation among the different institutions. Actual patient RT plan data should be collected to achieve reliable KROG 19 − 09 study results. BioMed Central 2022-11-16 /pmc/articles/PMC9670516/ /pubmed/36384804 http://dx.doi.org/10.1186/s13014-022-02140-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kim, Myeongsoo
Park, Boram
Kim, Haksoo
Kim, Yeon-Joo
Choi, Dong Ju
Chung, Weonkuu
Kim, Yeon Joo
Shin, Hyun Soo
Im, Jung Ho
Suh, Chang-Ok
Kim, Jin Hee
Ha, Boram
Kim, Mi Young
Park, Jongmoo
Lee, Jeongshim
Ahn, Sung-Ja
Lee, Sun Young
Kusumawidjaja, Grace
Lim, Faye
Cho, Won Kyung
Kim, Haeyoung
Choi, Doo Ho
Park, Won
Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer
title Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer
title_full Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer
title_fullStr Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer
title_full_unstemmed Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer
title_short Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer
title_sort dummy run quality assurance study in the korean radiation oncology group 19 − 09 multi-institutional prospective cohort study of breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670516/
https://www.ncbi.nlm.nih.gov/pubmed/36384804
http://dx.doi.org/10.1186/s13014-022-02140-0
work_keys_str_mv AT kimmyeongsoo dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT parkboram dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT kimhaksoo dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT kimyeonjoo dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT choidongju dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT chungweonkuu dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT kimyeonjoo dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT shinhyunsoo dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT imjungho dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT suhchangok dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT kimjinhee dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT haboram dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT kimmiyoung dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT parkjongmoo dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT leejeongshim dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT ahnsungja dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT leesunyoung dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT kusumawidjajagrace dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT limfaye dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT chowonkyung dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT kimhaeyoung dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT choidooho dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer
AT parkwon dummyrunqualityassurancestudyinthekoreanradiationoncologygroup1909multiinstitutionalprospectivecohortstudyofbreastcancer